Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 11, 2005, Pages 1298-1304

  Kizza, Harriet Mayanja ^a,d   Rodriguez, Benigno ^a,b   Quinones Mateu, Miguel ^c   Mirza, Muneer ^c   Aung, Htin ^a   Yen Lieberman, Belinda ^c   Starkey, Colleen ^c   Horter, Libby ^a   Peters, Pierre ^a,d   Baseke, Joy ^a,d   Johnson, John L ^a,b   Toossi, Zahra ^a,c,e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MAKERERE UNIVERSITY   (Uganda)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SUPERINFECTION; THORAX RADIOGRAPHY; UGANDA; VIRUS LOAD; VIRUS REPLICATION;

ADULT; BIOLOGICAL MARKERS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; TUBERCULOSIS, PULMONARY; UGANDA; VIRAL LOAD; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 27744505131     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.11.1298-1304.2005     Document Type: Article

References (32)

1. Badri, M., R. Ehrlich, R. Wood, T. Pulerwitz, and G. Maartens. 2001. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int. J. Tuberc. Lung Dis. 5:225-232.
2. Brown, M., M. Kizza, C. Watera, M. A. Quigley, S. Rowland, P. Hughes, J. A. Whitworth, and A. M. Elliott. 2004. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J. Infect. Dis. 190:1869-1879.
3. Bush, C. E., R. M. Donovan, N. P. Markowitz, P. Kvale, and L. D. Saravolatz. 1996. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13:23-26.
4. Cantin, R., J. F. Fortin, G. Lamontagne, and M. Tremblay. 1997. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 71:1922-1930.
5. Collins, K. R., H. Mayanja-Kizza, B. A. Sullivan, M. E. Quinones-Mateu, Z. Toossi, and E. J. Arts. 2000. Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis. J. Acquir. Immune Defic. Syndr. 24:408-417.
6. Collins, K. R., M. E. Quinones-Mateu, M. Wu, H. Luzze, J. L. Johnson, C. Hirsch, Z. Toossi, and E. J. Arts. 2002. Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J. Virol. 76:1697-1706.
7. Conover, W. 1980. Practical nonparametric statistics, 2nd ed., p. 213-344. John Wiley & Sons, New York, N.Y.
8. Falk, A., J. B. O'Connor, P. C. Pratt, W. R. Webb, J. A. Wier, and E. Wolinsky. 1969. Classification of pulmonary tuberculosis, p. 68-76. In Diagnostic standards and classification of tuberculosis. National Tuberculosis and Respiratory Disease Association, New York, N.Y.
9. Fleiss, J. L. 1981. Statistical methods for rates and proportions, 2nd ed., p. 61-82. John Wiley & Sons, New York, N.Y.
10. Girardi, E., G. Antonucci, P. Vanacore, M. Libanore, I. Errante, A. Matteelli, and G. Ippolito. 2000. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14:1985-1991.
11. Goletti, D., D. Weissman, R. W. Jackson, N. M. Graham, D. Vlahov, R. S. Klein, S. S. Munsiff, L. Ortona, R. Cauda, and A. S. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J. Immunol. 157:1271-1278.
12. Harries, A. D., N. J. Hargreaves, R. Chimzizi, and F. M. Salaniponi. 2002. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential. Bull. W. H. O. 80:464-469.
13. Kalayjian, R. C., A. Landay, R. B. Pollard, D. D. Taub, B. H. Gross, I. R. Francis, A. Sevin, M. Pu, J. Spritzler, M. Chernoff, A. Namkung, L. Fox, A. Martinez, K. Waterman, S. A. Fiscus, B. Sha, D. Johnson, S. Slater, F. Rousseau, and M. M. Lederman. 2003. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J. Infect. Dis. 187:1924-1933.
14. Keiper, M. D., M. Beumont, A. Elshami, C. P. Langlotz, and W. T. Miller, Jr. 1995. CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection. Chest 107:74-80.
15. Lawn, S. D., M. O. Labeta, M. Arias, J. W. Acheampong, and G. E. Griffin. 2000. Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin. Exp. Immunol. 120:483-487.
16. + macrophages at the site of pleural tuberculosis coinfection. J. Infect. Dis. 184:1127-1133.
17. Lawn, S. D., D. Rudolph, S. Wiktor, D. Coulibaly, A. Ackah, and R. B. Lal. 2000. Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively. Clin. Exp. Immunol. 122:79-84.
18. Lucas, S., and A. M. Nelson. 1994. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people, p. 503-513. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
19. Morris, L., D. J. Martin, H. Bredell, S. N. Nyoka, L. Sacks, S. Pendle, L. Page-Shipp, C. L. Karp, T. R. Sterling, T. C. Quinn, and R. E. Chaisson. 2003. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. J. Infect. Dis. 187:1967-1971.
20. Ostrowski, M. A., D. C. Krakauer, Y. Li, S. J. Justement, G. Learn, L. A. Ehler, S. K. Stanley, M. Nowak, and A. S. Fauci. 1998. Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J. Virol. 72:7772-7784.
21. Piroth, L., M. Duong, C. Quantin, M. Abrahamowicz, R. Michardiere, L. S. Aho, M. Grappin, M. Buisson, A. Waldner, H. Portier, and P. Chavanet. 1998. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 12:381-388.
22. Quan, C. M., M. Krajden, J. Zhao, and A. W. Chan. 1993. High-performance liquid chromatography to assess the effect of serum storage conditions on the detection of hepatitis C virus by the polymerase chain reaction. J. Virol. Methods 43:299-307.
23. Rodriguez, B., I. Woolley, M. M. Lederman, D. Zdunek, G. Hess, and H. Valdez. 2003. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients. J. Infect. Dis. 187:504-507.
24. Sabin, C. A., P. Telfer, A. N. Phillips, S. Bhagani, and C. A. Lee. 1997. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J. Infect. Dis. 175:164-168.
25. Sulkowski, M. S., R. E. Chaisson, C. L. Karp, R. D. Moore, J. B. Margolick, and T. C. Quinn. 1998. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J. Infect. Dis. 178:1642-1648.
26. Vanham, G., K. Edmonds, L. Qing, D. Hom, Z. Toossi, B. Jones, C. L. Daley, B. Huebner, L. Kestens, P. Gigase, and J. J. Ellner. 1996. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin. Exp. Immunol. 103:30-34.
27. Whalen, C., C. R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Ellner. 1995. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129-135.
28. Whalen, C. C., P. Nsubuga, A. Okwera, J. L. Johnson, D. L. Hom, N. L. Michael, R. D. Mugerwa, and J. J. Ellner. 2000. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 14:1219-1228.
29. Williams, C. F., D. Klinzman, T. E. Yamashita, J. Xiang, P. M. Polgreen, C. Rinaldo, C. Liu, J. Phair, J. B. Margolick, D. Zdunek, G. Hess, and J. T. Stapleton. 2004. Persistent GB virus C infection and survival in HIV-infected men. N. Engl. J. Med. 350:981-990.
30. Wong, S. B., S. H. Chan, and E. C. Ren. 1999. Diversity of GB virus C/hepatitis G virus isolates in Singapore: predominance of group 2a and the Asian group 3 variant. J. Med. Virol. 58:145-153.
31. Wright, T. L., H. Hollander, X. Pu, M. J. Held, P. Lipson, S. Quan, A. Polito, M. M. Thaler, P. Bacchetti, and B. F. Scharschmidt. 1994. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 20:1152-1155.
32. Ziegler-Heitbrock, H. W., and R. J. Ulevitch. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121-125.